Moderna says its new vaccine booster shows 'superior' response to omicron : NPR
Moderna on X: "@GovCanHealth has authorized the use of our Omicron-targeting #bivalent COVID-19 booster #vaccine, mRNA-1273.214, as a booster dose for active immunization against #COVID19 in individuals 18 years of age and
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
Some Who Rushed to Covid-19 Vaccine Hold Off on Boosters - WSJ
FDA clears extra COVID booster for some high-risk, older Americans | PBS NewsHour
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
FDA clears the way for additional bivalent boosters for certain vulnerable individuals | CNN
Vaccines and Boosters Offer Best Defense Against Omicron
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
Omicron's Evolution and the New Bivalent COVID-19 Booster | UC San Francisco
FDA advisors recommend using Covid omicron shots for all doses
Durability of Bivalent Boosters against Omicron Subvariants | NEJM
Pfizer, BioNTech find updated COVID booster protects against Omicron in trial | Reuters
Bivalent COVID-19 boosters may cut risk of severe disease by more than half | CIDRAP
U.S. Health Agencies Recommend First Omicron Booster Shot | Time
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
The Updated COVID Boosters Could Have Been Better | MedPage Today
COVID-19 Bivalent Boosters | Johns Hopkins | Bloomberg School of Public Health
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster | Nature Medicine
Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
FDA issues updated EUA for bivalent booster doses to fight omicron; providers to cease administration of monovalent boosters | AHA News
Second Omicron Booster Authorized | MedPage Today
Monovalent and bivalent COVID boosters provide strong protection against severe outcomes in older adults
Effectiveness of Bivalent Boosters against Severe Omicron Infection | NEJM
